School of Medicine
Showing 9,901-9,910 of 12,919 Results
-
Kathryne Sanserino
Clinical Assistant Professor, Obstetrics & Gynecology - Maternal Fetal Medicine
BioDr. Sanserino provides hospital-based obstetric and gynecologic care. She cares for patients admitted to Stanford Hospital with gynecologic problems. She also works at Lucille Packard on Labor and Delivery. She has a background in community health work in quality improvement. She is committed to safe, equitable health care and has a patient-centered, evidence-based practice approach.
Dr. Sanserino speaks fluent Spanish. -
Peter L. Santa Maria, MBBS, PhD
Associate Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Bioengineering
On Partial Leave from 08/01/2023 To 07/14/2024Current Research and Scholarly InterestsWe study chronic suppurative otitis media, a chronic biofilm infection of the middle ear predominantly involving pseudomonas and staph aureus. We are investigating mechanisms of sensory hearing loss, host microbe interactions and trialling novel therapeutics.
Our work in tympanic membrane regeneration has entered clinical trials.
Novel treatments for wound healing in intra oral wounds with potential applications to prevent post tonsillectomy wound healing and oral mucositis. -
Calvin Santiago
Clinical Instructor, Neurology & Neurological Sciences
BioDr. Santiago is Board-certified as a Fellow of the Royal College of Physicians of Canada, specializing in Neurology. He completed his Adult Neurology residency at the University of Toronto and is now a Clinical Instructor in the Division of Comprehensive Neurology at Stanford University. He provides comprehensive neurological care to patients with a broad range of neurological conditions. His academic interests focus on improving access to neurological care, such as reducing wait times and stream-lining referrals so that patients are directed to the most appropriate care provider.
-
Christine Santiago
Clinical Assistant Professor, Medicine
BioDr. Christine Santiago is a Clinical Assistant Professor in the Stanford Division of Hospital Medicine with a deep commitment to improving healthcare access and equity. Dr. Santiago earned her M.D. degree from Harvard Medical School graduating cum laude and completed an M.P.H. in Health Policy and Management at the University of California Berkeley.
Throughout her career, Dr. Santiago has actively engaged in various leadership roles and initiatives, such as co-founding the Stanford Health Equity, Advocacy and Research Program (Stanford HEARs), a resident-led program aimed at addressing healthcare disparities. She also had the privilege of serving as Chief Resident, where she supported educational activities and mentored fellow residents.
With a strong focus on diversity and inclusion, Dr. Santiago has been involved in multiple professional associations, including the American College of Physicians and the California Medical Association, to promote diversity within healthcare. Additionally, she has contributed to curriculum development, mentorship programs, and research activities, all in the pursuit of advancing healthcare, improving patient outcomes and creating a more equitable healthcare system for all patients. -
Matteo Santoro Pharm.D., Ph.D.
Postdoctoral Scholar, Pathology
BioDr. Santoro joined Shamloo’s lab in March 2021 focusing his research on Parkinson’s disease, neuronal vulnerability, and identification of therapeutic markers in relation to α-synucleinopathies. Prior to his arrival at Stanford, he held a position as a clinical monitor at Syneos Health where he gained key knowledge needed to translate lab-based findings into clinical and commercial applications. Previously, Dr. Santoro held a postdoctoral position at the University of Aberdeen (Scotland, UK) working on amyloid-beta extracts from Alzheimer’s disease patients. During his postdoctoral research, Dr. Santoro designed and optimized a cost-effective and rapid assay for the measurement of toxic amyloid-beta species in human biofluids. In 2017, he obtained his Ph.D. (4-year program) at the University of Aberdeen on Parkinson’s disease (PD), immunology, and behavior. The major findings Ph.D. findings were the following: 1) the characterization of a small protein called HMGB1 as an inflammatory mediator in PD; 2) the motor and non-motor behavioral characterization of three neurotoxin based mouse models of PD, 3) the characterization of the innate immune response in PD through the toll-like receptor signaling pathways 4) evaluation of the effects of chronic systemic inflammation on both resident and infiltrating immune cells in the CNS. In 2012 Dr. Santoro attained his Pharm.D. in chemistry and pharmaceutical technology (5-year program) at the University of Calabria (Italy) during which he undertook an internship at the King’s College London (SGDP Centre) and worked for over a year on a rat model of stroke.
